MarketWise (MKTW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Special Meeting scheduled for March 20, 2025, to vote on key corporate actions including a reverse stock split and reduction in authorized shares.
The Board recommends approval of all proposals, citing compliance with Nasdaq listing requirements and corporate flexibility.
Forward-looking statements highlight risks and uncertainties, especially regarding Nasdaq compliance and potential delisting.
Voting matters and shareholder proposals
Proposal 1: Approve a 1-for-20 reverse stock split, with the Board retaining discretion on timing and implementation.
Proposal 2: Approve a proportional reduction in authorized shares of all classes, contingent on the reverse split.
Proposal 3: Authorize adjournment of the meeting to solicit additional votes if needed.
All proposals require a majority vote; abstentions and broker non-votes may impact outcomes differently by proposal.
Board of directors and corporate governance
The Board unanimously recommends voting FOR all proposals.
Board retains authority to abandon the reverse split or authorized share reduction even if approved by shareholders.
No other business is expected at the meeting, but proxies may vote on unforeseen matters at their discretion.
Latest events from MarketWise
- Q4 2025 billings surged 42% YoY, FY 2026 guidance raised, and dividends increased.MKTW
Q4 20256 Mar 2026 - Q4 2024 saw a return to billings growth, improved margins, and renewed strategic focus.MKTW
Emerging Growth Conference 7810 Jan 2026 - Shareholders to vote on director elections, equity plan amendment, and new auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Vote to approve a 1-for-20 reverse stock split and reduce authorized shares for Nasdaq compliance.MKTW
Proxy Filing1 Dec 2025 - Key votes include director elections, incentive plan amendment, and auditor ratification.MKTW
Proxy Filing1 Dec 2025 - Q3 2025 net income was $17.9M on $81.3M revenue, with ARPU up 35.5% and a buyout proposal pending.MKTW
Q3 20256 Nov 2025 - Q2 2025 saw revenue and subscribers fall, but cash flow, billings, and capital returns strengthened.MKTW
Q2 20257 Aug 2025 - Net income rose to $22.7M in Q3 2024 despite sharp declines in revenue and subscribers.MKTW
Q3 202413 Jun 2025 - Net income surged to $21.2M in Q2 2024, while billings fell 40% amid Legacy Research wind-down.MKTW
Q2 202413 Jun 2025